We're taking a closer look at Hims & Hers Health today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -7.9% compared to 0.0% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:
-
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
-
Hims & Hers Health has moved 227.7% over the last year compared to 16.8% for the S&P 500 -- a difference of 210.9%
-
Its trailing 12 month earnings per share (EPS) is $0.79
-
Hims & Hers Health has a trailing 12 month Price to Earnings (P/E) ratio of 67.4 while the S&P 500 average is 29.3
-
Its forward earnings per share (EPS) is $0.46 and its forward P/E ratio is 115.8
-
The company has a Price to Book (P/B) ratio of 21.38 in contrast to the S&P 500's average ratio of 4.74
-
Hims & Hers Health is part of the Health Care sector, which has an average P/E ratio of 22.94 and an average P/B of 3.19
-
Hims & Hers Health has on average reported free cash flows of $20.78 Million over the last four years, during which time they have grown by an an average of 44.7%
